Andere Kunden interessierten sich auch für
![The Birth of Mankynde: Otherwyse Named the Womans Booke.]( "The Birth of Mankynde: Otherwyse Named the Womans Booke.")
The Birth of Mankynde: Otherwyse Named the Womans Booke.26,99 €![Moles, or Birth-marks, and Their Signification to Man and Woman]( "Moles, or Birth-marks, and Their Signification to Man and Woman")
Moles, or Birth-marks, and Their Signification to Man and Woman20,99 €![A Series of Articles On Speech-Defects As Localizing Symptoms, From a Study of Six Cases of Aphasia / by J.T. Eskridge]( "A Series of Articles On Speech-Defects As Localizing Symptoms, From a Study of Six Cases of Aphasia / by J.T. Eskridge")
A Series of Articles On Speech-Defects As Localizing Symptoms, From a Study of Six Cases of Aphasia / by J.T. Eskridge19,99 €![On Defects of Vision Which Are Remediable by Optical Appliances]( "On Defects of Vision Which Are Remediable by Optical Appliances")
On Defects of Vision Which Are Remediable by Optical Appliances20,99 €![Optimal Birth]( "Optimal Birth")
Optimal Birth43,99 €![Anatomy and Congenital Defects of the Ligamentum Pectinatum [electronic Resource]]( "Anatomy and Congenital Defects of the Ligamentum Pectinatum [electronic Resource]")
Anatomy and Congenital Defects of the Ligamentum Pectinatum [electronic Resource]15,99 €![An Introduction to the Study of the Optical Defects of the Eye, and Their Treatment by the Scientific Use of Spectacles [microform]]( "An Introduction to the Study of the Optical Defects of the Eye, and Their Treatment by the Scientific Use of Spectacles [microform]")
An Introduction to the Study of the Optical Defects of the Eye, and Their Treatment by the Scientific Use of Spectacles [microform]15,99 €
![Anatomy and Congenital Defects of the Ligamentum Pectinatum [electronic Resource]](https://bilder.buecher.de/produkte/65/65501/65501191m.jpg "Anatomy and Congenital Defects of the Ligamentum Pectinatum [electronic Resource]")
![An Introduction to the Study of the Optical Defects of the Eye, and Their Treatment by the Scientific Use of Spectacles [microform]](https://bilder.buecher.de/produkte/65/65629/65629550m.jpg "An Introduction to the Study of the Optical Defects of the Eye, and Their Treatment by the Scientific Use of Spectacles [microform]")
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation.